5 Spam-Free Article(s) Found
||Pacific Biosciences of California, Inc.
Nov 02, 2018 - PacBio's years of commercial execution struggles come to an end, with Illumina announcing its intention to buy the company for $8/share.Illumina should be able to meaningfully improve the margins of t
Nov 16, 2018 - llumina (ILMN) set to take over peer in a $1.2-billion deal, which will strengthen its position in the genomics market.
Dec 06, 2018 - Pacific Biosciences (PACB) is likely to gain from strong prospects in the Sequel System platform. However, the company faces cutthroat competition in the DNA sequencing market.
Dec 24, 2018 - Strategy for profiting in up, sideways, or down markets. Capture a double discount – deal spreads plus retail investor panic. This worked well in 2009 and could work well in 2019.
Jan 04, 2019 - Luminex (LMNX) scores higher than Pacific Biosciences (PACB) considering growth projections and fundamentals.